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In 2014, Oak Ridge Institute for Science and Education (ORISE) published a pa-
per outlining dose coefficients for intakes of radionuclides via wounds. Thirty-eight
(38) nuclides were identified that are commonly encountered in industrial, medical,
or research applications, which included 3H, 14C, 32P, 35S, 59Fe, 57,58,60Co, 85,89,90Sr,
99mTc, 106Ru, 125,129,131I, 134,137Cs, 192Ir, 201Tl, 210Po, 226,228Ra, 228,230,232Th, 234,235,238U,
237Np, 238,239,240,241Pu, 241Am, 242,244Cm, and 252Cf.
The dose coefficients are a predicted effective dose or organ dose per Bq of in-
take. These dose coefficents can be used to create Clinical Decision Guides (CDGs),
which are an emergency response tool to assist in deciding if decorporation methods
are necessary if a radionuclide contamined wound occurs. For the work completed
by ORISE, the CDGs give an activity level that would result in a clinically signifi-
cant dose based on National Council on Radiation Protection (NCRP) Report 161
[1]. The NCRP recommendations are to use the most restrictive of the following
[2]:
• 250 mSv effective dose
• 250 mGy 30-day Relative Biological Effectiveness (RBE)-weighted dose to
the thyroid or red blood marrow
• 1 Gy 30-day RBE-weighted dose to the lungs
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RBE is a way of comparing radiation quality. It is the ratio of absorbed dose
for two types of radiation that will produce the same biological endpoint, such as a
certain percent of cells surviving [3]. An RBE-weighted dose is the absorbed dose in
a tissue multiplied by the RBE for that radiation producing a specific endpoint in
the tissue [4]. For the RBEs in these recommendations the NCRP used RBE values
of two and seven for alpha radiation to the bone marrow and lungs respectively for
consideration of deterministic effects [2].
CDGs are given for select radionuclides in the report, but a CDG can be de-
termined for any of the 38 radionulcides by dividing the dose limit by the effective
dose coefficient. Table 1.1 shows a summary of the ORISE CDGs determined for
the selected radionuclides.
Table 1.1: ORISE CDGs with restricting dose parameter [1].
Radionuclide Dose Parameter CDG (Bq)
3H (HTO) Effective 1.4 · 1010
32P Effective 1.1 · 108
90Sr Bone Surface 5.9 · 106
131I Thyroid 6.7 · 105
137Cs Effective 1.8 · 107
210Po Effective 1.4 · 105
235U Effective 1.4 · 105
239Pu Bone Surface 4.9 · 102
241Am Bone Surface 4.5 · 102
The dose coefficients and CDGs in this report are meant to be used as a response
tool only, and not a method of determining doses after an incident.
1.2 Thesis Objectives
The ORISE dose coefficients only consider material that has been cleared from
the wound site - there is no consideration made to the dose received locally due
to radionuclide retention at the wound site. This leaves a gap in the analysis of
whether a clinically significant dose could occur or not.
The objectives of this thesis are as follows:
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1. Create a model of an injection wound and investigate an appropriate wound
size.
2. Perform Monte Carlo radiation transport simulations, using the code Monte
Carlo N-Particle (MCNP), to determine the dose received by the 38 radionu-
clides.
3. Calculate local dose coefficients for injection wounds.
4. Create models of other relevant wound types to investigate the effect on dose
coefficients.
5. Perform Monte Carlo radiation transport simulations, using the code MCNP,
to calculate the dose received by the 38 radionuclides by alternate wounds.
6. Calculate local dose coefficients for alternate wound types.
7. Provide recommendations on local activity limits to avoid clinically significant
doses.
1.3 Thesis Outline
The purpose of this thesis is to develop local dose coefficients due to radionuclide
contamination in wounds for use in emergency response. Chapter 1 outlines the
scope of research done. Chapter 2 outlines the background knowledge necessary
for the research. Chapter 3 outlines the methodology used to complete MCNP
simulations and mathematical models. Chapter 4 is an overview and discussion of






The primary purposes of skin are to assist in homeostasis and thermoregulation, as
well as provide a protective layer for the rest of the body. Skin consists of several
different layers, which can be seen in Figure 2.1.
The outermost layer of skin, labeled 1 in Figure 2.1, is the epidermis, which can
be further broken into several more layers. Figure 2.2 shows these layers. The top
part of the dermis is called the stratum corneum and consists of dead cells. Some
parts of the body, like the soles of the hands and feet, have an additional layer
of dead skin cells called the stratum lucidum. Next is the stratum granulosum
is a transition layer of both dead and alive cells. Following that is the stratum
spinosum, which are live but post-mitotic cells. The final layer is referred to as
the stratum germinativum, or basal layer. The basal layer consists of mitotic cells,
where the cells divide and produce the cells required for the other layers of the
epidermis [5].
After the epidermis is the dermis, which has two layers. The first is the papillary
layer, labeled 2 in Figure 2.1. The papillary layer is responsible for thermoregu-
lation. Second is the reticular layer, labeled 3 in Figure 2.1. The reticular layer
consists of the structural components of skin, like collagen and elastin [5].
The final layer is the subcutis, or hydodermis, labeled 4 in Figure 2.1. It consists
of fatty and connective tissues. It also has specialized structures located in the skin,
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Figure 2.1: Photomicrograph of skin [5].
like sweat glands and hair follicles. Below the subcutis muscle begins [5].
2.1.2 Healing
The healing of most wounds occurs in three stages - inflammation, reepithelializa-
tion, and formation of granulation tissue. After a wound occurs, there will likely be
damage to blood vessels. This leads to bleeding, and the formation of blood clots
to close off the blood vessels and start filling any space created in the skin with the
wound. Inflammatory polymorphonuclear leukocytes, a type of white blood cell,
will begin cleaning the wound site of foreign material, such as bacterial or partic-
ulates. If the foreign material is too large, monocytes and macrophages may go to
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Figure 2.2: Layers of the epidermis [5].
the wound site. Monocytes are another type of white blood cell, and macrophages
are a cell that come from monocytes. Over time, a foreign-body reaction could oc-
cur if there is material at the wound site that cannot be removed by the monocytes
or macrophages. If a chronic inflammatory response occurs the foreign material
will be isolated by encapsulation in a fibrous capsule [6].
Reepithelialization begins a few hours after a wound occurs and involves ep-
ithelial cells from around the edges of the wound moving to cover the wounded
area. These cells can rapidly divide in order to form a scab over the wound. Reep-
ithelialization can last for two or three days [6].
The final stage is the formation of new granulation tissue. This happens around
four days after the wound occurs, and involves new collagen going to the wound
site and capillaries being formed. After around two or three weeks this stage is
complete and a scar may be formed [6].
Burns heal similarly to other wounds, however they may heal slower depending
on the severity of the burn. Severe burns lead to cell necrosis, so there could be a
reduction in circulation of blood at the burn site, which impairs it’s ability to heal
[6].
Chapter 2. Background 7
2.2 NCRP Wound Model
NCRP Report 156, Development of a Biokinetic Model for Radionuclide Contam-
inated Wounds and Procedures for Their Assessment, Dosimetry and Treatment,
provided the base for modeling radionulcide retention and transportation from
wounds for the work completed by ORISE. An overview of data available on ra-
dionuclide contaminated wounds found that there is documentation of over 2,000
contaminated wounds. The majority of the wounds took place in facilities dealing
with components of nuclear weapons, and typically involved actinides. Addition-
ally, more than 90% of the wounds occured on hands and arms, with fingers being
the most common, and the vast majority of the wounds were punctures. These
factors impacted the focus on injection wounds, as it would be most applicable to
real cases [6].
The NCRP wound model is shown in Figure 2.3. This model consists of 5
compartments in which radionuclides could exist at the wound site, as well as two
removal compartments, the lymph nodes and the blood. Once material reaches
the lymph nodes or blood and is cleared from the wound site, it is not necessarily
cleared from the body right away. For example, if a wound was contaminated with
131I, once it was cleared from the wound a large part of the iodine would likely
accumulate in the thyroid if stable potassium iodide pills were not taken. The
wound model assumes an injection as the wound type. This is largely due to lack
of data available for other wound types, however there likely would be changes in
the biokinetics based on the type of severity of the injury. This would likely result
in radionuclides being retained at the wound site for different amounts of times
when compared to injection wounds [6].
In the general wound model, the soluble and Colloid & Intermediate State (CIS)
compartments consist of soluble materials. The difference between the two is the
size of the particles - solutions have smaller particles than colloids. The soluble
compartment is further classified as weakly, moderately, strongly, or avidly retained
at the wound site, which is determined experimentally but is related to the ability
of the material to hydrolyze, as well as its ability to form stable compounds at
the wound site. The Particles, Aggregates, & Bound State (PABS) and fragment
compartments consist of solid material, again with the main difference between
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Figure 2.3: NCRP general wound model. Adapted from [6].
them being the size. Particles are below 20 µm, which corresponds with the size
of particles that can be phagocytized by macrophages.
The wound model can be simplified if the initial injection is modeled as one of
the four starting compartments - PABS, fragment, CIS, or soluble. Figures 2.4,
2.5, 2.6, and 2.7 show these simplified models, respectively.
For the particle model, material can transfer to the soluble compartment, or it
can be removed from the wound site through the lymph system if it is phagocy-
tized. It could also be transferred to the Trapped Particles & Aggregates (TPA)
compartment. The TPA compartment models particles that follow different bioki-
netics due to fibrous encapsulation of particles. There is bidirectional movement
between these two compartments. Material in the PABS state can slowly become
soluble, where it can then be cleared from the wound site through the blood [6].
The fragment model is fairly similar to the PABS model, with the exception
being material will move from a fragment to a particle or soluble state, rather
than starting as a particle. Fragments may also become encapsulated, like particle,
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Figure 2.4: NCRP wound model for a particle injection. Adapted
from [6].
however the biokinetics are not expected to be as impacted as particles, so trapped
fragments are not considered [6].
The colloid and soluble model are identical, except for the initial state of the
material. Material can move bidirectionally between the soluble or CIS compart-
ments. If a material reacts with water or surrounding materials more readily, it will
likely shift towards the CIS compartment. From the soluble compartment material
can be removed from the wound site through blood, but from the CIS or PABS
compartment removal from the site happens through the lymph system [6].
To complete these models, transfer rates between the different compartments
are specified so that a series of first order differential equations can be defined for the
movement of material in a wound, and the removal from the wound. These transfer
rates were largely found by modeling data from animal testing. For example,
transfer rates for the soluable model were found using data from injecting material
into rats. Data was found on the retention of material at the wound site over
time, which was used in the NCRP models to generate rate constants between the
compartments [6].
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Figure 2.5: NCRP wound model for a fragment injection. Adapted
from [6].
Figure 2.6: NCRP wound model for a colloid injection. Adapted
from [6].
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Figure 2.7: NCRP wound model for a soluble injection. Adapted
from [6].
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2.3 Effects of Radionuclides in Wounds
The effects of radiation can be divided into two categories - deterministic effects
and stochastic effects. Deterministic effects occur once a threshold dose has been
reached. For example, changes in white and red blood cell count are seen from
whole body doses of 250-500 mGy. Stochastic effects have an increased probability
of occurring with increased radiation exposure. The most common example of this
is your risk of developing cancer can increase with increased exposure to radiation
[7].
2.3.1 Deterministic Effects
For the consideration of whole body effects of radionuclide contamination in wounds
the limiting deterministic effects occur to the lungs or red bone marrow, depending
on the radionuclide. Pulmonary syndrome can occur as a deterministic effect of
radiation exposure to the lungs. It occurs in two stages. In the first, the lungs
may become inflamed and it may be difficult to breathe for up to several months.
The second stage is the long term damage caused by loss of alveoli [8], which are
small sacs of air in the lungs involved in transferring oxygen to blood [9]. For
red bone marrow, haematopoietic syndrome is the concern. If the blood marrow
is irradiated, the precursors to blood cells may be killed and the ability for new
blood cells to be generated is diminished. This can lead to increased bleeding and
a diminished capability to fight infections [8].
Local deterministic effects will be considered for the skin. Erythema, or a
redness of the skin, is the most common effect. Erythema can have different causes.
The first is just redness of the skin due to inflammation, which usually goes away
after one or two days. If the basal layer of the skin was damaged by the radiation,
there can be more severe erythemas. Dry desquamation occurs when keratin is
is found in the affected skin due to a reduction of cells in the basal layer. Moist
desquamation happens when the epidermis is lost because of a reduction of cells
in the basal layer. Epilation, or loss of hair, can also occur. Desquamation and
epilation usually occur around three to six weeks after exposure. In serious cases
of moist desquamation, there could be secondary damage done due to dehydration
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and infection, in which case an ulcer can form. This can cause dermal necrosis,
where dermal tissue dies. When it grows back, dermal atrophy, a thinning of the
dermal tissue, occurs [5].
2.3.2 Stochastic Effects
Stochastic effects for both whole body effects and local effects come down to risk
of contracting a fatal cancer. For the ORISE dose limits, taken from the NCRP
Report 161 guidelines for CDGs, the limit is an effective dose of 0.25 Sv over 50
years. Based on a cancer fatality risk of 5% Sv-1, this results in 1.3% increase in
risk [2]. For local effects, again considering the skin, the risk of cancer depends on
the size and location of skin exposed. The risk of skin cancer changes depending
on how much UV radiation it is exposed to. Skin on areas like the hands, which
are often exposed, would be at a higher risk than skin on an area like the back,
which is often covered by clothing. The risk of skin cancer also changes with the
size of the area exposed. Overall, the risk of developing a fatal skin cancer is lower
than developing a fatal cancer when whole body effects are being considered.
2.4 Decorporation Therapy
One of the first measures to clean a radionuclide contaminated wound is to irrigate
it to wash out as much contamination as possible, although if there is contamination
on the skin surrounding the wound care should be taken to not further contaminate
the wound [6]. If it is still suspected that there will be a significant intake of
radionuclides, additional decorporation methods may be considered.
Blocking agents are used to saturate a body with a stable isotope before or
shortly after exposure to a radioactive isotope. If the body is saturated, it sig-
nificantly reduces the amount of the radioactive isotope absorbed by the body.
A common example of this is potassium iodide pills to protect the thyroid from
radioiodine [10] .
Chapter 2. Background 14
Decorporation therapies that involve switching radioisotopes for stable isotopes
include displacement and ion exchange. Displacement involves using a stable iso-
tope to displace a radioisotope, for example, calcium gluconate will displace ra-
dioactive strontium in bones. Ion exchange is also used to replace radioisotopes,
with a common example being Prussian Blue. Prussian Blue uses an ion exchange
reaction to help remove cesium the body, and is still effective with time if therapy
is not started immediately [10].
Chelation therapy is commonly used for intakes of actinides. Diethylene-Triamine-
Pentaacetate (DTPA) is a common chelating agent. It comes in two forms, calcium-
DTPA and zinc-DTPA. Calcium-DTPA is more effective shortly after an incident,
but after about 24 hours the efficiency of the two are equal so zinc is preferred
because it is less toxic for long term use. Both work by exchanging the zinc or
calcium for a metal that can form stronger bonds, like actinides. The DTPA will
end up in the kidneys, where it will be excreted through urine. DTPA should be
started as soon as possible after an incident [6].
Decorporation therapy could also involve surgery to physically remove material
from the wound site. This must be carefully considered to ensure the side effects
of the surgery will not be greater than those of the contamination. However, this
can be a very effective method of removing material from the site shortly following
an accident [10].
2.5 Monte Carlo Methods and MCNP
Monte Carlo simulations model stochastic events using probabilities of different
outcomes and randomly generated numbers. A Monte Carlo simulation can be
done for any random event - for example, you could set up a simulation to see
how many time a six would be rolled on a dice. However, Monte Carlo simulations
can also be used to simulate complicated scenarios, such as particle transport, by
breaking the scenario down into much simpler random events [11]
Chapter 2. Background 15
2.5.1 Probability Functions
Two probability functions are important to Monte Carlo simulations - Probability
Density Functions (pdfs) and Cumulative Density Functions (cdfs). A pdf, p(x)dx,
gives the probability that x will be a specific value between x and dx. pdfs must
be normalized so that the integral probability of x being between x and dx is one.
As an example, consider a disk with a spinner where the angle of the spinner, φ, is
measured after each spin, as shown in Figure 2.8.
Figure 2.8: Spinner used in probability function example.
If it is a fair spinner, there is an equal probability of spinning any given angle
between 0 and 2π, so the pdf is given by Equation 2.1 [12].
p(φ) = k (2.1)
Where k is a constant. Since the total probability must be equal to 1, the value
of the constant k can be found with the integration shown in Equation 2.2:
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∫ 2π
0
kdφ = 1 (2.2)





The cdf gives the probability that x does not exceed a specific value. The cdf for
a scenario can be obtained from the pdf by integrating the pdf across its potential











2.5.2 Fundamental Formation of Monte Carlo
The fundamental formation of Monte Carlo provides a method of relating the
probability functions for a scenario to a random number, η, that is between 0 and
1. x and η can be related through their pdfs, as seen in Equation 2.6:
p(x)dx = p(η)dη for a ≤ x ≤ b and 0 ≤ η ≤ 1 (2.6)
Integrating both sides of Equation 2.6 over the range of both variables leads to
a more useful relationship. It was already established that integrating a pdf gives
you the cdf. For η to generate random numbers between 0 and 1, Equation 2.7
must be true.
p(η) = 1 for 0 ≤ η ≤ 1 (2.7)
This means that Equation 2.6 can be simplified to Equation 2.8:
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P (x) = η (2.8)
Equation 2.8 gives the final form of the fundamental formation of Monte Carlo
[12].
2.5.3 Sampling Techniques
Sampling techniques for Monte Carlo simulations ensure that the random numbers
generated fit with the probability distributions of the situation being modeled. The
easiest sampling technique is analytical inversion, where the fundamental formation
of Monte Carlo is inverted to get an equation where random result x is a function
of random number η [12]. Going back to the example of finding the angle of a






Now Equation 2.9 can be inverted, which gives the angle from a random number
η between 0 and 1, as shown in Equation 2.10:
φ = 2πη (2.10)
For more complex distributions, it may not be possible to create an equation
that describes a random event based on η through analytical inversion. There are
many other methods of ensuring the random numbers fit within the probability
functions. One alternate method is numerical inversion. In this method, the pdf is
split into equiprobable sections. The two random numbers can be generated - the
first to selected the section to sample from, and the second to generate a random
number between the bounds of the section. Another method, called the rejection
technique, involves enclosing the pdf in an area bound by the maximum values of
the pdf. This will create a rectangular area to sample from, so two random numbers
can be used to generate an x coordinate between a and b, which are the minimum
and maximum values being sampled from, and the y coordinate is between 0 and
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the maximum value of the pdf. Once a coordinate is generated, it can be checked
to see if it would be bound by the pdf, or if it would fall between the pdf and the
rectangular boundary. If it does not fall under the pdf, it will be rejected and a
new coordinates will be generated [12].
2.5.4 MCNP
MCNP is a program that will model very complex situations by breaking them
down into small, random pieces. The central limit theorem states that a simulation
for a random variable, x, is repeated a large number of times the results will be
normally distributed about the true average value of x [13]. As an example, consider
the transport of a photon generated from an isotropic source. Some things that
would need to be considered are the initial energy, the initial direction, and if
any interactions happen. MCNP will break this up into smaller simulations - for
example, since it is an isotropic source the polar and azimuthal angles would be
equally sampled to get a starting direction, and the probabilities of interactions
occurring would be based off of cross section data for the materials involved [11].
Monte Carlo simulations, and MCNP, can be used to generate a pdf of a much more
complicated event based on these smaller simulations. For example, you could use
MCNP to create a pdf of what the average photon energy is if it reaches a specific
point in the room. Each successful particle run will lead to a data point for the
generation of the pdf, and if enough trials are run the mean value of the trials will





The following section will discuss the MCNP models used. Three models were
made to simulate different wound types - an injection, an abrasion/burn, and a
laceration. All 38 radionuclides were modeled for each wound type using MCNP
Version 6.1.1. Although MCNP Version 6.2 was released during the course of this
research, none of the new features were deemed necessary.
An MCNP file consists of three cards - surfaces, cells, and data. Surface cards
define surfaces in MCNP, such as planes, spheres, cylinders, cones, etc. Cell cards
define areas based on planes. For example, 6 planes can be used to define a cube.
Data cards can hold a variety of different information depending on the problem.
Some examples are [14]:
• Mode - specifies which particles are being modeled in the problem.
• Cell and Surface Parameters - specifies information relevant to a specific cell
or surface. This could include the volume of a complex cell, or the importance
of particles in cells.
• Source Specification - specifies characteristics of the source in the problem.
This includes information like the location, size, energy, and bias of the
source.
• Tally Specification - specifies what information the code should be tracking,
such as the flux in a cell or across a surface, or the energy deposited in a cell.
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• Material Specification - specifies the composition of materials used in the
problem.
3.1.1 Materials
In MCNP, there are two parts to setting up materials. Nuclides must be specified
using ZAID numbers. These numbers are in the format ZZAAA, where Z is the
atomic number and A is the atomic mass of the desired nuclide. The second part is
giving each ZAID an atomic or weight percentage to fully specify the composition
of the material.
The materials used in all three models were a combination of skin and air, the
composition of which can be seen in Tables 3.1 and 3.2, respectively.
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A void area is set up around the problem to establish a boundary for the
model. Void areas are not assigned a material. If a particle enters the void area, it
is immediately terminated and the next particle is run.
These models are all thicker than skin is on the human body. In the case of a
puncture wound, a 1 cm sphere around the wound would likely encompass muscle
or other material as well. However, since a wound can occur anywhere on the body
it is impossible to say what the composition around a wound would be ahead of
time. Skin was used as a simplification, and the composition of skin and muscle
do not differ greatly. Since this is a response tool, and not a method of calculating
exact doses received from injuries it should be a reasonable assumption.
3.1.2 Particles Modeled
Most of the radionuclides modeled produce multiple types of radiation. In order
to reflect all types of radiation in the local dose coefficients, multiple files can be
run with the same geometry, but a different source particle. The results of each
run can then be weighted to how many of those particles are produced and added
to get the total energy deposited per disintegration. This is discussed further in
Section 3.4.
Betas
There are two forms of beta decay - β− and β+. In β− decay, a neutron is trans-
formed into a proton, and an electron and antineutrino are ejected from the nu-
cleus. The equation for β− decay is shown in Equation 3.1. β− decay occurs in
radionuclides with a lot of neutrons [17].
A
ZP →AZ+1 D + β− + v̄ (3.1)
For β+ decay, a proton is transformed to a neutron, and a positron and and
neutrino are ejected from the nucleus. The equation for β+ decay is shown in
Equation 3.2. β+ decay occurs in radionuclides that have a lot of protons, but not
enough energy to undergo alpha decay [17].
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A
ZP →AZ−1 D + β+ + v (3.2)
In both β− and β+ decay, the energy of ejected electrons/positrons are a con-
tinuous spectrum, rather than discrete values.
Beta spectrums can be modeled in MCNP by specifying energy points along
the beta spectrum, and assigning a probability for generating an electron in each
of the energy ranges. Within the data ranges energies are sampled equally. All
beta spectrum data was obtained from RadToobox. RadToolbox can automatically
produce beta spectrums in a Monte Carlo format, and outputs the data in 10 equal
energy bins with corresponding probability [18].
Along with the source particles, the MCNP model can generate photons and
additional electrons through various reactions. The most significant of these is
delta rays. Charged particles may ionize atoms if they have sufficient energy,
which causes an electron to be ejected from an atoms orbit. If the ejected electron
has sufficient energy, it may also produce several ionizations, and is called a delta
ray [7]. A much smaller amount of electrons are also created through Compton
Scattering and the Photoelectric Effect. Photons are mainly produced through
Bremsstrahlung. Bremsstrahlung is is x-rays emitted when charged particles, like
electrons, undergo an acceleration, such as slowing down in a material [7].
Monoenergetic Electrons
Monoenergetic electrons consist of Auger electrons and internal conversion elec-
trons. Internal conversion electrons are produced when an excited nucleus ejects
an electron and x-rays [17]. The Auger effect occur when a photon from an elec-
tron filling a lower energy vacancy interacts with a second electron, causing it to
be ejected [7].
Monoenergetic electrons are modeled separately from betas because they have
discrete energy levels, so rather than setting up the energy bins as histograms with
a probability between two energy bins, they are set up as discrete energies with a
probability of producing each value. Monoenergetic electron data was taken from
RadToolbox. However, since many radionuclides have a large number of very low
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probability Auger or internal conversion electrons, only events that contribute more
than 0.1% of the energy times intensity were included in the models.
Similarly to the beta files, additional electrons can be generated due to delta
rays, and a small amount from Compton Scattering and the Photoelectric Effect.
Photons can also be created due to Bremsstrahlung.
Photons
Photons consist of gamma and x-rays. Gammas can be emitted from an excited
nucleus returning to ground state, while x-rays are emitted when electrons move
to lower energy states. Both gammas and x-rays have discrete energy levels, rather
than a continuous spectrum of possible energies [7].
Like monoenergetic electrons, many radionuclides have a large number of very
low probability photon energies, so only events that contributed more than 0.1%
of the energy times intensity in RadToolbox were included in the models.
In the photon files, electrons could be created due to the Photoelectric Effect
and Compton Scattering. These electrons could create more electrons through
delta rays, or additional photons through Bremsstrahlung.
Alphas
Alpha decay occurs when a parent radionuclide emits an alpha particle. The equa-
tion for alpha decay is shown in Equation 3.3. Alpha decay occurs in radionuclides
that have a lot of protons [17].
A
ZP →A−4Z−2 D + α (3.3)
The energy of emitted alpha particles are discrete values. All possible alpha
energies from RadToolbox were used in the MCNP models. The alpha models
do not include other generated particles. In MCNP 6.1.1, delta ray generation
from heavy charged particles is not possible. This feature was released in MCNP
6.2, and some alpha files were tested with this feature, however it did not make a
difference to the results. This is likely due to the low energies of the alpha particles
in this research. At lower energies, alpha particles will not produce many delta
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rays. If they were produced, they would not have contributed a significant dose
when compared to the alpha particles, and not make a noticeable difference to the
results.
3.1.3 Tallies
MCNP has eight standard tallies which provide information like current, flux, and
energy depositions. For all models, the standard F6 tally was used for energy
deposition in a cell. The cell of interest is the cell that represents skin, which is
shown in green in all the figures of the models in the following sections.
The F6 tally gives the energy deposition in a cell in MeV/g/source particle. A
modifier was used, the +F6 tally, so that all secondary particles generated would
be considered in the tally results. This tally is essentially a track length tally with
a collision heating multiplier to result in energy deposition [19].
3.1.4 Geometry
In MCNP, the geometry of problems is set up using surfaces and cells. Surfaces
may be simple like planes or spheres, to more complicated shapes like ellipsoids
or paraboloids. The cells use boolean operations to define the intersection and
union of difference surfaces. Cell cards also specify what material and density the
composition of the cell has [14].
The MCNP Visual Editor (VisEd) was used while generating the geometries
for this research. The VisEd is a program to assist in the creation of MCNP input
files. It consists of tools for creating the surfaces and cells of a MCNP files, as well
as allows for the geometry to be visualized with 2-D or 3-D views. Another use is
inputting a source and creating particle track plots [20], however this feature was
not used.
Injection
Figure 3.1 shows the geometry of the injection model. It consists of a sphere of
skin with an isotropic point source in the middle. Everything outside the sphere
of skin is void.
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Figure 3.1: MCNP VisEd model of injection geometry.
There is no standardized mass or size for a wound, so the injection model was
run with radii of 0.25 cm, 0.5 cm, and 1 cm for each of the 38 radionuclides.
These initial sizes where chosen by looking at electron ranges from the National
Institute of Standards and Technology. The Continuous-Slowing-Down Approxi-
mation (CSDA) range is a close approximation of the path length a charged particle
travels as it comes to rest [25]. These initial A sample code for the injection model
can be found in Appendix H. 32P has the highest energy of the beta emitters, with
an average beta energy of 695 keV [18]. The CSDA range is 2.800·10-1 g/cm2 [26],
or considering the density of skin 0.26 cm. To compare with a lower energy beta
emitter, 14C, the average beta energy is 49.4 keV [18]. The the CSDA range for
14C is 4.342·10-3 g/cm2 [26], or 0.004 cm in skin. The model size starts at approx-
imately the range of an average 32P beta and is increased to fully encompass a
larger range of beta energies.
Laceration
Figure 3.2 shows the geometry of the laceration model. This model is a cube of
skin with side lengths of 1 cm. There is a cut through the skin that extends from
the center line of the cube to the top face, with an angle of 5◦ between the faces of
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skin. The material in the laceration is air. There is an isotropic line source along
the bottom of the cut. Everything outside the cube of skin and cut is considered
void. A sample code for the cut model can be found in Appendix H
Figure 3.2: MCNP VisEd model of laceration geometry.
The size of the laceration model was chosen so that the results of the cut CDGs
will be in units of Bq/cm. Similarly to injections, there is not a standardized size
for a cut to be. However with a laceration, the size of the actual wound can vary
greatly. As an example, consider a radionuclide with a Local Wound Guide (LWG)
of 10,000 Bq. If there is a small laceration measuring 1 cm in length and a larger
laceration measuring 5 cm, both with an activity of 15,000 Bq, the smaller cut is
likely going to be of a higher concern due to the smaller volume. By putting the
laceration LWGs in terms of their length, so the LWG for this radionuclide would
be 10,000 Bq/cm it is clear that a contaminated cut 5 cm long would likely not be
of concern unless the activity was 50,000 Bq. The two faces of the cube that are
perpendicular to the cut are specularly reflective, so if a particle intersects with
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that plane it will bounce off in the same way light reflects from a mirror. This
would imitate a particle being generated further along the cut.
Along with the laceration model, a healed cut model was made, which is just
the cube with a isotropic line source down the center. The healed cut would be
more accurate over longer time frames because a cut does not stay open for very
long - clotting to begin filling the cut occurs very quickly after the wound and
reepithelialization to cover the wound begins after a few hours.
Abrasion/Burn
Figure 3.3 shows the geometry of the abrasion or burn model. Abrasions and burns
use the same MCNP model because they are both an injury that occurs over an
area of the skin. It consists of a cube with side lenths of 1 cm, with material of
the cube split down the middle. In Figure 3.3, the blue side is air and the green
side is skin. There is a surface source across the skin on the surface where the skin
and air meet. This source is biased so that particles only go in the direction of the
skin. The four rectangular planes of the skin are reflective surfaces, so if a particle
intersects with them it will bounce off, imitating a particle that was generated
outside the wound. Everything outside the cube of skin and air is considered void.
A sample code for the abrasion/burn model can be found in Appendix H.
The size of the abrasion model was chosen so the results will be in units of
Bq/cm2. Similarly to a cut, the size of a laceration or burn can vary greatly
between injuries. Again, consider a radionuclide with a LWG of 10,000 Bq. If
there is a contaminated scrape with an area of 1 cm2, and a contaminated scrape
with an area of 5 cm2, both with an activity of 15,000 Bq, the larger one may not
be of concern due to the larger area. If the LWG is in terms of the area of the cut,
so 10,000 Bq/cm2, it is easier to determine that the larger scrape may not be of
concern unless the activity is 50,000 Bq.
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Figure 3.3: MCNP VisEd model of abrasion/burn geometry.
3.2 MCNP Errors and Statistics
MCNP provides various statistics on each simulation, which are used to perform
ten statistical tests. These numbers can be used to get an understanding of whether
data is meaningful, however they do not provide an indication of a model being
correct. A model could be set up incorrectly, for example, the source could be set up
with the incorrect energy, but the stats could still pass. While the statistic would
indicate a successful simulation, the results would not be a accurate representation
of the desired situation. The results of output files should be carefully checked to
ensure both the model and results are reasonable.
3.2.1 Tally Mean
The tally mean is the result of the MCNP model. For example, if you are looking
for the average energy of a particle at a specific surface, the tally mean will be the
average of all the histories at that surface. There is one statistical test associated
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with the tally mean. For the second half of the histories the tally mean can only
randomly fluctuate as the number of particles, N , increases. The tally mean can
not show any trends increasing or decreasing [13].
3.2.2 Relative Error
The relative error that MCNP calculates for each tally has two components, Reff
and Rint. The relative error is given by Equation 3.4 [13]:
R2 = R2eff +R
2
int (3.4)
Reff represents the error due to scoring inefficiencies. The more particles that
do not contribute to the tally, the higher Reff will be. Rint represents the error
due to the spread of the non-zero histories. The larger the spread of the data for
scoring histories, the larger Rint will be. A R of 0 would represent a tally in which
all histories counted the same value towards the tally [13].
In order for the results of an MCNP tally to be considered meaningful, R must
be less than 0.1, or less than 0.05 if ring or point detectors are being used [14].
No ring or point detectors are used in any of the wound models, so 0.1 is the
acceptable relative error for all tallies in this work. This is the second statistics
check. There are two others associated with the relative error. The relative error
must only decrease as N increases, and it also must decrease with
√
N [13].
3.2.3 Figure of Merit





T is the simulation time for the tally. The FOM for a tally should remain con-
stant throughout the duration of the simulation, except at the beginning, because
T is proportional to N and R2 is inversely proportional to N [13]. If the FOM is
not constant, it could be an indication that the tally is not converging on a result
[21].
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There are two statistic checks for the FOM for the second half of the histories.
The FOM must remain statistically constant and it can not have any upwards or
downwards trends [13].
3.2.4 Variance of the Variance
The Variance of the Variance (VOV) is an estimate of the variance of the relative
error. This is a useful statistic because it is more sensitive to oversampling of high
scoring but infrequent events. There are three statistic checks for the VOV. It
must have a value less than 0.1, and for the second half of the problem it must
show a downwards trend and decrease as 1/N [13].
3.2.5 Tally pdf
MCNP creates a pdf for the tally to help ensure that if the problem has infrequent
but high scoring events they are not underestimated in the tally mean. If they
are overestimated, the VOV checks will likely catch it. The final statistic check is
that the slope of the pdf for the 201 highest scoring histories must be greater than
3. This is essentially checking if enough histories were run that the central limit
theorem is valid [13].
3.3 Dose Limits
Selecting a local dose limit for radionuclide contamination in wounds is difficult
because there are a large amount of unknowns. A wound could occur anywhere on
the body, and it could be any size. It will be assumed that skin will be the primary
organ impacted for local concerns. Skin doses are generally assigned to the basal
layer or the dermal layer, however these doses are looking at the entire model of
skin. Again, this assumption is being made because this is not a tool for assigning
dose but a tool for quickly estimating if decorporation may be necessary. It would
not be possible for such a tool to encompass all situations, nor would the relevant
data be available at the time of an injury, so assumptions must be made.
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Estimating stochastic effects is complicated because estimates of skin cancer
risk are generally for external radiation. Based on relative risk, which is the ratio
of cancer in people with exposure to the people without [22], the risk of a fatal
skin cancer is 2·10-4 Sv-1. This is for a whole body exposure though. NCRP 130
gives examples of weighting the exposure from hot particles based on the area
exposed [23]. The average adult has about 18,000 cm2 of skin. In the wound
models, the cross sectional area is at most 1 cm, so this is about 5.5·10-3% of the
body. This leads to a weighted risk of fatal skin cancer of 1.1·10-8 Sv-1. This risk
would indicate that deterministic effects are the limiting factor when looking at
doses to the skin [5]. However, these risks are assuming an external source, so the
risk from a wound may be higher because the proximity of the source to the basal
layer of the skin, which is the concern for stochastic effects, may differ. Risks of
skin cancer for partial exposures also vary greatly depending on the skin exposed
and the individual sensitivity of exposure. Skin that is is regularly exposed to
ultraviolet radiation is usually more susceptible to cancer than skin that is usually
covered. But even that can vary based on skin pigmentation [23].
For deterministic effects, ICRP 59 recommends that lifetime skin doses be less
than 30 Gy. It is further recommended that the limit for chronic skin exposures
be less that 0.5 Sv in a year [5], which remains the recommendation in ICRP 103
[24]. This is the limit that will be used in this work. In general, the dermal layer
is the concern for deterministic effects [5].
3.4 Injection Calculations
3.4.1 Dose Coefficients
There are two main components to the calculation of the dose coefficients - the
dose per nuclear transformation, and the number of transformations per Bq that
occur in the time period the dose is being calculated for.
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Dose per Transformation
The energy deposited in the skin per nuclear transformation is found using MCNP.
As discussed in Section 3.1.2, there are up to four MCNP files per radionuclide
depending on the type of decay - a beta, alpha, photon, and monoenergetic electron
file. The output of each MCNP file gives the average energy deposited per gram per
particle. The results of each of the appropriate MCNP files must be normalized for
one disintegration. This is done using intensity data from RadToolbox. Multiplying
each category of radiation by its intensity and adding them together gives the total
energy per transformation.
Since MCNP gives the energy deposited in MeV/g, a conversion factor of 1.602 ·
10−10 must be applied. This converts the results to J/kg, or Gy. Finally, in order
to get an equivalent dose in Sv the radiation weighting factors must be applied.
This only matters for the alpha files, where the results will be multiplied by 20
[24].
As an example, data from the MCNP files for an injection of 60Co is given in
Table 3.3. This example utilizes a beta, monoenergetic electron, and photon file.
Table 3.3: Sample data for 60Co.
Beta ME Photon
MCNP Output (MeV/g) 1.90 · 10−1 4.18 · 10−1 2.64 · 10−2
Intensity 1.0 1.50 · 10−3 2.0
Weighting Factor 1 1 1
Conversion Factor 1.602 · 10−10 1.602 · 10−10 1.602 · 10−10
Product 3.04 · 10−11 1.00 · 10−13 8.46 · 10−12
Adding the products from Table 3.3 gives a final value of 3.91 · 10−11 Sv per
nuclear transformation. An equivalent calculation can be done for each of the
radionuclides modeled.
Transformations per Becquerel
In order to find out how many nuclear transformations will occur in a given amount
of radioactive material, radioactive decay must be considered. As time goes on,
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Where A(t) is the activity at time t, A0 is the initial activity, and λ is the
decay constant. To find the total number of transformations, Equation 3.6 can be






Equation 3.7 gives the total number of transformations that would occur. How-
ever, because there is biological removal of material from the wound site through
the blood or lymphatic fluids, calculating the number of transformations using only
the radioactive decay will result in an overestimation of the dose coefficient. NCRP
156 provides equations to model the retention at the wound site for the 7 initial
conditions - weak, moderate, strong, avid, colloid, particle, and fragment. The






Where R(t) is the retention at the wound site at time t, in the form of percent
of initial deposition, t is the time after the deposition in days, Ai is the percent of
deposited radionuclides that fall into component i of the equation, and λi is the
rate constant for component i in days-1. Each equation is given 2 or 3 components
with different clearance rates for radioactive material from the wound. The default
parameters were found by fitting curves to experimental data. Table 3.4 shows the
default parameters for use with Equation 3.8.
Equation 3.9 shows an example of one of the retention equations, using the
parameters for a weakly retained radionuclide [6].
R(t)Weak = 55e
−55t + 40e−6t + 5e−0.1t (3.9)
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Table 3.4: Default biokinetic parameters for radionuclide retention
at wound sites [6].
Category A1 (%) λ1 (d-1) A2 (%) λ2 (d-1) A3 (%) λ3 (d-1)
Weak 55 55 40 6.0 5.0 0.1
Moderate 55 55 35 0.5 10 0.02
Strong 50 1.0 30 0.03 20 0.001
Avid 19 37 81 0.001 - -
Colloid 15 3.0 8 0.055 77 7 · 10−4
Particle 5 0.05 95 4 · 10−4 - -
Fragment 0.5 0.009 99.5 6.5 · 10−6 - -
This equation shows that the default biokinetic model for weakly retained ra-
dionuclides consists of 3 components. The first component indicates that 55% of
the material is cleared with a rate constant of 55 days-1, or about a 20 minute half
life. 40% of the material is cleared with a rate constant of 6 days-1, or about a
2.75 hour half life. The remaining 5 percent is cleared with a rate constant of 0.1
days-1, or a half life of about 7 hours.
In order to get a more accurate idea of the activity at the wound site at a time
after the initial deposition, the activity at that time would need to be multiplied
by the percentage of material retained at the wound site. Equation 3.10 gives
the equation for the activity at time t when considering the biological removal or





Where A(t) is found using Equation 3.6, R(t) is found using Equation 3.8 with
the appropriate parameters from Table 3.4, and the factor 1
100
is included because
the results for R(t) are not already in the form of a decimal percentage. As an
example, the equation for activity over time with biological removal for a weakly





(55e−55t + 40e−6t + 5e−0.1t) (3.11)
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Taking the integral of Equation 3.11 will give the total number of transfor-
mations that occur between the initial deposition and t while accounting for both


























Equivalent equations to Equations 3.11 and 3.12 for each of the initial material
categories were set up using the parameters from Table 3.4, however only the weak
equations are shown as examples.
3.4.2 Local Wound Guides
Once the dose coefficients are found, the calculation of a LWG is straight forward





It is important to ensure that the time frame that the dose limit is being taken
over is the same time frame the dose coefficients were calculated for. For example,
if the dose coefficients are calculated for a life time dose of 50 years, they can be
used to generate activity guidelines that correspond with life time dose limits. The
dose coefficients would not be useful in calculating an activity guideline for a 30
day dose.
3.5 Laceration, Abrasion, and Burn Calculations
The calculation of dose coefficients and LWGs for lacerations, abrasions, and burns
follow the same methods as for injections, with some adjustments made to the
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biokinetic models. The equations for the default biokinetic model, outlined in
Equation 3.8 and Table 3.4 were developed using injections. There is limited ex-
perimental work done on the biokinetics of radionuclides in other wounds, and the
work that has been done is over a short time period for soluble initial conditions.
For lacerations and abrasions, radioactive materials were applied to wounds
made on rats. The material cleared from the wound sites was tracked over 24
hours, and compared to expected clearance rates from an injection. It was found
that for both lacerations and abrasions there was very little difference for weakly
retained radionuclides, but for moderately retained radionuclides 50% of the ex-
pected material was cleared, 20% for strongly retained radionuclides, and 5% for
avidly retained radionuclides [6].
For burns, experiments were done on rats that involved both burning their skin
thermally and with acid and applying solutions. The thermally burned skin did not
have much of a difference over intact skin. For intact skin, the weak and moderate
absorption was 2.5% the expected amount from an injection, and the strong and
avid was 0.2%. The results from the acid burning indicated that absorption might
be higher from an acid burn, but did not recommend a trend. A third type of burn
is radiation burns. There was no animal data collected for this, but follow up from
the 137Cs accident in Gioânia, Brazil, showed long term retention of 137Cs in scar
tissue in people who suffered radiation burns [6].
If the trends found for early absorption in these studies continue, it would mean
that using the default biokinetic equations for wounds other than injections could
result in underestimating the material retained at the wound site, and underes-
timating the dose coefficient. This would in turn lead to LWGs that were not
restrictive enough.
To compensate for this, the rate constants from Table 3.4 will be adjusted
by a factor equivalent to the expected reduction in absorption. For example, the
expected absorption for a cut contaminated with a moderately soluble radionuclide
is 50% of that expected for an injection at 24 hours, so the rate constants will
be multiplied by 0.5. Table 3.5 shows the modified rate constants for each for
lacerations and scrapes, and Table 3.6 shows the modified rate constants for burns.
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Table 3.5: Modified biokinetic parameters for radionuclide reten-
tion for lacerations and abrasions.
.
Category λ1 (d-1) λ2 (d-1) λ3 (d-1)
Weak 55 6.0 0.1
Moderate 27.5 0.25 0.01
Strong 0.2 0.006 2 · 10−4
Avid 1.85 5 · 10−5 -
Table 3.6: Modified biokinetic parameters for radionuclide reten-
tion for burns.
.
Category λ1 (d-1) λ2 (d-1) λ3 (d-1)
Weak 1.375 0.15 0.0025
Moderate 1.375 0.0125 5 · 10−4
Strong 0.002 6 · 10−5 2 · 10−6
Avid 0.0745 2 · 10−6 -
Figure 3.4 shows the default biokinetic equation plotted with the modified equa-
tion for lacerations and abrasions. The modified equation does not reach a 50%
difference as soon as 24 hours after the injury, however it does have a higher re-
tention rate than the original equations. Due to the lack of data, especially in the
long term, these equations will be used as an approximation of the retention.
Since these studies looked at soluble materials, and not insoluble, there are
no suggestions for how radionuclide retention would differ from injections. Since
insoluble materials are retained longest for injection injuries, and the absorption
for different types of wounds is reduced, biological removal will not be considered
for colloids, particles, or fragments for wounds other than injections. They will be
grouped as insoluble, and the transformations per Bq will only consider radioactive
decay. The equation for this was given by Equation 3.7.
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4.1 Data Overview and Analysis
Due to the large amount of data generated, most results can be found in the
Appendices. For each of the wound types, 38 radionuclides were modeled and
data was calculated for each of the 7 initial retention categories. Appendix A,B,
C, and D contain the dose coefficients for the injection, laceration, abrasion, and
burn models, respectively. Appendix E, F, and G contain the results of the MCNP
simulations for the injection, laceration, and abrasion/burn models respectively.
While data has been calculated for all retention categories, not all categories
have been observed for all radionuclides. Including all retention categories is to
mimic the ORISE data in completeness. Some radionuclides can be assigned a
default retention category for when they are in a soluble form [1]. These default
parameters will be used to show some sample data.
4.1.1 Injection Model
Model Size
ICRP 59 recommends taking care in selecting the size for skin doses because if the
dose is found over too large an area it would be an underestimation of the true dose.
By finding the dose over an unnecessarily large area, the same amount of energy
will be deposited in a larger mass, and the dose will appear smaller. To ensure
an appropriately sized injection model was used, each radionuclide was modeled 3
times with different radii - 0.25 cm, 0.5 cm, and 1 cm.
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A particle run in MCNP may be terminated for a few different reasons, in this
work mainly because it hits it’s energy cutoff or it escapes the area of interest.
The ideal model size for alphas and electrons would be the size that minimizes the
amount of particles that can escape the volume. If a large number of particles were
able to escape the volume, the dose could be taken over too small a volume and
neglect a dose to the surrounding area. However, if the model is too large the dose
could be underestimated due to the excess mass. Since photons travel further in
tissue than alphas and betas, the size of the wound model is not adjusted for them.
They will not have a large impact locally due to their range.
The output files for MCNP provide data on how particles are terminated. For
electrons, it was found that for low energy emitters, like 3H or 14C, no electrons
escaped at a 0.25 cm radius. However for high energy beta emitters, such as 32P,
or for some monoenergetic electron files, like for 59Fe, electrons are able to escape
the problem area, the skin, before they reach their lower energy cutoff. For 32P,
about 1% of the electrons escape. This includes both the source electrons and the
delta rays, MCNP does not differentiate between the two. By increasing the model
radius to 0.5 cm, it reduces the number of escaped electrons to about 0.05%, and by
increasing the model radius to 1 cm there are virtually no escapes (three electrons
out of around 25 million). As a compromise between the low and high energies, a
0.5 cm radius was used for calculations, however local dose coefficients can easily
be found for the other model sizes with the MCNP data.
For the alpha emitters, no alphas were able to escape the model at any of the
sizes, so a 0.25 radius is used for the calculations. This will result in in higher
energy electrons being able to escape, however the alphas contribute more to the
dose due to their high energy.
Sample Data
Table 4.1 shows the local dose coefficients and LWGs for injections of select ra-
dionuclides at their default soluble retention category. This data, and all data in
Appendix A is for a dose of 0.5 Sv in a one year time frame, or the ICRP 59 recom-
mendation to avoid deterministic effects for a chronic skin exposure [5]. The dose
coefficients generated are equivalent dose coefficients over a 1 year time period.
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The 0.5 Sv in one year could be multiplied out to a 25 Sv dose in 50 years, however
that would have resulted in a significantly higher dose than 0.5 Sv in some of the
beginning years. The results would have been very far off for radionuclides with a
short half life, or for the models that are not retained well at the wound site. For
example, 99mTc has a half life of 6.015 hours. This means that after about 2 days, a
negligible amount would remain at the wound site due to radioactive decay alone.
If a larger dose was calculated, it would be calculated in those 2 days, and clinical
effects would almost certainly occur.
Table 4.1: Sample data for injection model with default retention
parameters.
Radionuclide Category Dose Coefficient (Sv/Bq) LWG (Bq)
Sr85 Weak 1.60 · 10−11 3.13 · 1010
Sr89 Weak 8.44 · 10−11 5.92 · 109
Sr90 Weak 3.18 · 10−11 1.57 · 1010
Tc99m Weak 1.02 · 10−12 4.91 · 1011
I125 Weak 2.69 · 10−11 1.86 · 1010
I129 Weak 1.04 · 10−11 4.80 · 1010
I131 Weak 1.95 · 10−11 2.56 · 1010
Cs134 Weak 3.30 · 10−11 1.52 · 1010
Cs137 Weak 3.10 · 10−11 1.61 · 1010
Po210 Strong 1.15 · 10−6 4.35 · 105
Ra226 Moderate 3.24 · 10−8 1.54 · 107
Ra228 Moderate 4.40 · 10−12 1.14 · 1011
Th228 Avid 6.37 · 10−6 7.85 · 104
Th230 Avid 1.33 · 10−6 3.75 · 105
Th232 Avid 5.56 · 10−6 8.99 · 104
U234 Weak 1.36 · 10−8 3.69 · 107
U235 Weak 1.42 · 10−8 3.51 · 107
U238 Weak 1.81 · 10−9 2.77 · 108
Pu238 Strong 2.20 · 10−6 2.27 · 105
Pu239 Strong 2.07 · 10−6 2.41 · 105
Pu240 Strong 2.07 · 10−6 2.41 · 105
Pu241 Strong 8.02 · 10−11 6.23 · 109
Am241 Strong 2.20 · 10−6 2.27 · 105
Cm242 Strong 1.43 · 10−6 2.18 · 105
Cm244 Strong 2.29 · 10−6 2.18 · 105
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Error Analysis
There are two areas where error could be introduced to these results - the MCNP
simulations and the application of the general biokinetic models from NCRP 156.
For error in MCNP, the recommendation of keeping the relative error under 0.1
was followed for all simulations. All uncertainties are listed in Appendix E. All 10
statistical checks were also passed for each simulation. This would indicate that
the simulation did converge on a reasonable result. One interesting point to be
made of the relative errors for alpha particles is that most of them were 0. This
is due to their short range, so all histories will count towards the tally, as well as
the small spread of possible energies leading to similar results for each particle. A
trial was run with an imaginary alpha source with a greater spread in potential
energies, and that resulted in a nonzero relative error.
As an additional check of the MCNP results, a hand calculation can be per-
formed to estimate the dose from a single beta or alpha particle. To test the beta
files, the average energy from a 14C beta can be divided by the mass of the injection
model with a 0.5 cm radius, as shown in Equation 4.1.
4.92 · 10−2 MeV
5.71 · 10−1 g
= 8.62 · 10−2 MeV/g (4.1)
The MCNP result for 14C in the 0.5 cm injection model is 8.69·10-2 MeV/g,
so the results of the MCNP result are reasonable. A similar check was performed
on alphas to ensure the results were reasonable. For alphas and betas, it can be
assumed that the full energy of the particles will be deposited into tissue when
performing hand calculations for verification. With gammas, the amount of energy
deposited in the skin around the wound, or the specific absorbed fraction, is not
known. However, since the alpha and beta particles produce reasonable results
with the MCNP model, it will be assumed that the gammas are also reasonable.
The injection model will have the least error introduced through accounting
for biological removal because it most closely resembles the biokinetic models for
radionuclide retention at wound sites. The default biokinetic equations established
in NCRP Report 156 were based off intramuscular injections, or injections past
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the skin and into muscle tissue. Limited data is available for subcutaneous injec-
tions, which is the layer of connective tissue between the skin and muscle. Studies
were done looking at short term radionuclide retention at the site of subcutaneous
injections in rats. After one week it was found that for some radionuclides there
is slightly less retention at the wound site for subcutaneous injections, however it
was similar enough that it was recommended to use the same model as intramuscu-
lar injection. This could result in the LWGs being overly conservative for shallow
puncture wounds. However, retention at the wound site will also vary with other
factors such as concentration of radionuclide if the contamination is a solution, or
biological differences between different people. It is also not practical to require an
accurate measurement of how deep an injection is for an emergency response tool,
so the default models will be sufficient.
4.1.2 Laceration Model
Model Size
In Section 3.1 the laceration model was introduced as a cube with 1 cm side lengths.
After the analysis of the appropriate size for injection models, the laceration model
was adapted for alpha emitters to also have a smaller volume. The cut is still 1
cm long, so the results are still relative to the length of the injury. However the
lengths of the other sides have been reduced to 0.5 cm so a rectangular prism is
formed instead of a cube, as seen in Figure 4.1.
The shorter side lengths were also applied to the healed cut model, which would
look like Figure 4.1, but without the cut of air. All files associated with an alpha
emitter were run with the modified model, and all other files were run with the
original model.
Sample Data
Table 4.2 shows the dose coefficients and LWGs for contaminated cuts with select
radionuclides at their default soluble retention category. This data, and all data
in Appendix B is for a dose of 0.5 Sv in a one year time frame. Since a year is a
long time when compared to the time it takes a cut to heal, the healed cut model
Chapter 4. Results and Analysis 44
Figure 4.1: Laceration model adapted for alpha particles.
is used to calculate dose coefficients and LWGs. The MCNP data for both models
can be found in Appendix F. However there is very little difference between the two
sets of data, so it is unlikely that an open wound model would make a difference
in the results, even in the short term. As discussed in Section 3.1.4, the units for
the local dose coefficients for lacerations are in the unit of Sv/Bq·cm to account
for the different sizes of lacerations that may occur.
Error Analysis
The MCNP errors are similar to the injection models. The relative uncertainties for
all simulations were under 0.1 and all statistics tests were passed for all simulations,
which would indicate that the problem converged on a reasonable value for the
given model. The relative uncertainties can be seen in Appendix F. For open
cuts, the relative errors for alpha simulations were greater than zero because a
small amount of alphas escaped through the cut, leading to less than 100% of the
particles contributing to the tally. For the healed cuts the alpha relative errors were
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back to 0 because they all counted towards the tally. Hand calculations indicated
that the results of the MCNP files were reasonable.
Applying the biokinetic models to cuts will introduce error into the values. As
discussed in Section 3.5, the biokinetic equations were based on injections, and
studies show that short term clearance from the wound site is less than what it
would be for an injection. By modifying the biokinetic equation, it reduces the
clearance from the wound site indefinitely, not just in the first 24 hours. If the
clearance from the wound site is actually more similar to the clearance from an
injection over time, then this is a conservative assumption and the dose coefficients
will be high. If the clearance is further reduced with time, then the calculated dose
coefficients will be too low, and the LWGs will not be restrictive enough.
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Table 4.2: Sample data for laceration models with default reten-
tion parameters.
Radionuclide Category Dose Coefficient (Sv/Bq·cm) LWG (Bq)
Sr85 Weak 1.03 · 10−11 4.86 · 1010
Sr89 Weak 4.43 · 10−11 1.13 · 1010
Sr90 Weak 1.66 · 10−11 3.01 · 1010
Tc99m Weak 6.86 · 10−13 7.29 · 1011
I125 Weak 1.43 · 10−11 3.51 · 1010
I129 Weak 5.45 · 10−12 9.17 · 1010
I131 Weak 1.05 · 10−11 4.76 · 1010
Cs134 Weak 1.88 · 10−11 2.66 · 1010
Cs137 Weak 1.62 · 10−11 3.08 · 1010
Po210 Strong 3.86 · 10−6 1.30 · 105
Ra226 Moderate 6.79 · 10−8 7.36 · 106
Ra228 Moderate 6.24 · 10−12 8.02 · 1010
Th228 Avid 1.56 · 10−5 3.20 · 104
Th230 Avid 3.30 · 10−6 1.51 · 105
Th232 Avid 1.38 · 10−5 3.63 · 104
U234 Weak 2.84 · 10−8 1.76 · 107
U235 Weak 2.98 · 10−8 1.68 · 107
U238 Weak 3.78 · 10−9 1.32 · 108
Pu238 Strong 7.54 · 10−6 6.63 · 104
Pu239 Strong 7.10 · 10−6 7.04 · 104
Pu240 Strong 7.11 · 10−6 7.03 · 104
Pu241 Strong 2.75 · 10−10 1.82 · 109
Am241 Strong 7.55 · 10−6 6.62 · 104
Cm242 Strong 4.81 · 10−6 1.044 · 105
Cm244 Strong 7.87 · 10−6 6.36 · 104
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4.1.3 Abrasion/Burn Model
Model Size
Similarly to the laceration model, the original abrasion/burn model was adjusted
for alpha particles based on the size chosen for the injection models. The interface
between skin and air was kept at 1 cm2 in order to keep the relationship between
the size of the wound and the results. However the depth of the skin and air was
changed to 0.25 cm, instead of 0.5 cm. The updated model can be seen in Figure
4.2. All files associated wtih an alpha emitter used the modified model, and all
other files used the original model. As discussed in Section 3.1.4, the units for
the local dose coefficients for abrasions and burns are in the unit of Sv/Bq·cm2 to
account for the different sizes of abrasions or burns that may occur.
Figure 4.2: Abrasion/burn model adapted for alpha particles.
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Sample Data
Table 4.3 shows some sample data for abrasions contaminated with select radionu-
clides at their default soluble retention category, and Table 4.4 shows samples data
for burns. All local dose coefficients and LWGs for abrasions and burns are based
on a 1 year dose, and a 0.5 Sv dose limit. Results for all retention categories can
be found in Appendix C and D .
Error Analysis
The error analysis for abrasions and burns is very similar to the errors for cuts.
Negligible errors would be introduced by MCNP since all relative errors were under
0.1 and all statistics tests were passed. Hand calculations indicated the results
from MCNP were reasonable. There is error introduced through accounting for
biological removal from the wound site since the default biokinetic equations are
modeled after injections. This is accounted for by modifying the equations as
discussed in Section 3.5, however this is based on the assumption that the reduction
in clearance will continue past 24 hours. If over time the clearance of material from
these wounds more closely resembles the clearance from an injection over time, this
is a conservative assumption and the dose coefficients will be high. If the clearance
from the wound site further slows with time, then the dose coefficients will be too
low, leading to LWGs that are not restrictive enough.
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Table 4.3: Sample data for abrasion model with default retention
parameters.
Radionuclide Category Dose Coefficient (Sv/Bq·cm2) LWG (Bq)
Sr85 Weak 1.05 · 10−11 4.77 · 1010
Sr89 Weak 4.05 · 10−11 1.23 · 1010
Sr90 Weak 1.50 · 10−11 3.34 · 1010
Tc99m Weak 6.94 · 10−13 7.21 · 1011
I125 Weak 1.29 · 10−11 3.87 · 1010
I129 Weak 4.93 · 10−12 1.01 · 1010
I131 Weak 9.62 · 10−11 5.20 · 1010
Cs134 Weak 1.79 · 10−11 2.80 · 1010
Cs137 Weak 1.46 · 10−11 3.41 · 1010
Po210 Strong 1.93 · 10−6 2.59 · 105
Ra226 Moderate 3.40 · 10−8 1.47 · 107
Ra228 Moderate 2.10 · 10−12 2.38 · 1011
Th228 Avid 7.81 · 10−6 6.40 · 104
Th230 Avid 1.65 · 10−6 3.03 · 105
Th232 Avid 6.89 · 10−6 7.26 · 104
U234 Weak 1.42 · 10−8 3.52 · 107
U235 Weak 1.49 · 10−8 3.36 · 107
U238 Weak 1.89 · 10−9 2.65 · 108
Pu238 Strong 3.77 · 10−6 1.33 · 105
Pu239 Strong 3.55 · 10−6 1.41 · 105
Pu240 Strong 3.56 · 10−6 1.41 · 105
Pu241 Strong 1.32 · 10−10 3.78 · 109
Am241 Strong 3.78 · 10−6 1.32 · 105
Cm242 Strong 2.41 · 10−6 2.08 · 105
Cm244 Strong 3.93 · 10−6 1.27 · 105
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Table 4.4: Sample data for burn model with default retention
parameters.
Radionuclide Category Dose Coefficient (Sv/Bq·cm2) LWG (Bq)
Sr85 Weak 2.43 · 10−10 2.06 · 109
Sr89 Weak 4.64 · 10−10 1.08 · 109
Sr90 Weak 3.87 · 10−10 1.29 · 109
Tc99m Weak 2.75 · 10−12 1.82 · 1011
I125 Weak 1.57 · 10−10 3.18 · 109
I129 Weak 1.29 · 10−10 3.89 · 109
I131 Weak 7.36 · 10−11 6.79 · 109
Cs134 Weak 4.21 · 10−10 1.19 · 109
Cs137 Weak 3.79 · 10−10 1.32 · 109
Po210 Strong 4.65 · 10−6 1.07 · 105
Ra226 Moderate 1.72 · 10−6 2.90 · 105
Ra228 Moderate 1.03 · 10−10 4.87 · 109
Th228 Avid 7.95 · 10−6 6.29 · 104
Th230 Avid 1.685 · 10−6 2.983 · 105
Th232 Avid 7.01 · 10−6 7.14 · 104
U234 Weak 3.70 · 10−7 1.35 · 106
U235 Weak 3.89 · 10−7 1.29 · 106
U238 Weak 4.93 · 10−86 1.01 · 107
Pu238 Strong 9.99 · 10−6 5.01 · 104
Pu239 Strong 9.41 · 10−6 5.32 · 104
Pu240 Strong 9.42 · 10−6 5.312 · 104
Pu241 Strong 3.49 · 10−10 1.43 · 109
Am241 Strong 1.00 · 10−5 5.00 · 104
Cm242 Strong 5.88 · 10−6 8.50 · 104
Cm244 Strong 1.04 · 10−5 4.81 · 104
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4.2 Model Comparison
In this section, graphs of the local equivalent dose coefficients for select radionu-
clides will be presented as a way to compare the data obtained from the different
wound models. While these graphs would not be a useful way of presenting this
data for emergency response, but this is a useful for looking at some trends ex-
hibited by the data. For these graphs, the abrasion and burn dose coefficients are
given for a 1 cm2 area and the laceration dose coefficients are given for a 1 cm long
cut.
Figure 4.3: Graph of local equivalent dose coefficients for 3H.
Figure 4.3 shows the dose coefficients for 3H. The injection, abrasion, and lac-
eration follow a similar shape. The difference in the values is due to differences in
the MCNP geometry, as well as the modifications made to the default biokinetic
equations for lacerations and abrasions. The dose coefficients for burns are higher
because of the very strong retention at the wound site for burns, even for weakly
retained radionuclides.
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Since the colloid, particle, and fragment categories for abrasions, burns, and
lacerations did not consider biological removal, they have the same value for those
categories and the lines level off. The values for abrasions and burns for the insolu-
ble categories are identical because they are using the same MCNP model, and the
same calculation for number of transformations, Equation 3.7. The injection dose
coefficients continue to rise across colloids, particles, and fragments because models
exist for the biokinetics for injections, so biological removal is still considered.
In these graphs, the dose coefficients trend upwards across the soluble categories
except burns between strongly and avidly retained. The avidly retained dose coef-
ficient is actually slightly lower than that of the strongly retained. This is because
in the default biokinetic equations described in Table 3.4, a portion of an avidly
retained material is cleared faster than strongly retained material. When these
parameters are modified for burns, given in Table 3.6, it causes the retention at the
wound site to be lower for a avidly retained radionuclide for about 200 days. After
that, the avid retention is higher than the strong retention. Because the effective
dose coefficients are calculated over a one year period, this results in the strongly
retained dose coefficient to be slightly higher than the avidly retained one. The
difference is not large, the average percent difference between the two categories
is 8%. Since there are no biokinetic models for burns, it is hard to say if this is
a reasonable approximation of what is happening. However, since the dose coeffi-
cients for the strong and avidly retained radionuclides are very close to the dose
coefficients for the insoluble categories, which are maximum values since biological
removal is not considered, they are likely conservative values.
Figure 4.4 shows the dose coefficients of 32P, which is another beta emitter.
However, for 32P the dose coefficients for the injection, abrasion, and laceration
model are closer to those of the burn model, especially at the strong retention
category. This is likely due to the small half life of 32P, which is about 14 days.
This means that the material would be essentially gone due to radioactive decay
after a little over 3 months, so the difference in retention at the wound site between
the different models becomes less important.
Figure 4.5 shows the dose coefficients of 60Co, which undergoes β− decay, but
most frequently decays to an excited state and also emitts two gammas. The
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Figure 4.4: Graph of local equivalent dose coefficients for 32P.
general trends in the dose coefficients are undisturbed by the emission of gammas.
Finally, 4.6 shows the dose coefficients of 210Po, an alpha emitter. The most
notable change in this graph is the difference between the laceration and abrasion
dose coefficients. In the previous graphs, they are much closer together. The
primary reason for this is differences in MCNP geometry. In the previous section,
the modified laceration and abrasion models for alpha particles were introduced.
The original models were both the same size, so for radionuclides that are not
alpha emitters the volume over which the abrasion and laceration dose coefficients
were being calculated was constant. For the alpha modified geometries, the volume
of skin in the laceration model is half the volume in the abrasion model, so the
abrasion model will have a smaller dose coefficient when a 1 cm2 abrasion and 1
cm long cut are used.
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Figure 4.5: Graph of local equivalent dose coefficients for 60Co.
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Figure 4.6: Graph of local equivalent dose coefficients for 210Po.
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4.3 ORISE Comparison
In the ORISE paper, nine radionuclides were selected for sample CDGs based on
their default soluble retention category. Table 4.5 shows the selected CDGs with
their corresponding LWG for comparison. The LWGs in this table are for the
injection model because all CDGs were modeled based on injections.
Table 4.5: Comparison of CDGs and LWGs for select radionu-
clides.
Radionuclide Category CDG (Bq) LWG (Bq)
H3 Weak 1.4 · 1010 5.47 · 1011
P32 Weak 1.1 · 108 7.17 · 109
Sr90 Weak 5.9 · 106 1.57 · 1010
I131 Weak 6.7 · 105 2.56 · 1010
Cs137 Weak 1.8 · 107 1.61 · 1010
Po210 Strong 1.4 · 105 3.32 · 104
U235 Particle 1.4 · 105 7.83 · 103
Pu239 Strong 4.9 · 102 3.02 · 104
Am241 Strong 4.5 · 102 2.84 · 104
If a contaminated wound occurs, the most restrictive activity limit should be
used to limit the dose, which would be the smaller activity. For the select radionul-
cides and retention categories shown in Table 4.5, the restrictive case is is the CDG
for everything but 210Po and 235U.
Whether the CDG or LWG will be restrictive depends on a few factors. One
of the main ones is the retention category of the radionuclide. For weakly and
moderately retained radionuclides, the clearance rate from the wound is relatively
quick, so the CDG is likely to be restrictive. Another impact is how the radionuclide
is retained in the body. 210Po and 239Pu are both strongly retained alpha emitters,
and they have similar LWGs, but their CDGs are two orders of magnitude different.
This is because 239Pu is more strongly retained in the body than 210Po [27], so it
has a greater effect specifically on the bones than locally at the wound site. Since
210Po is not as avidly retained by the body once is it cleared from the wound site,
it has a more significant impact to the wound site.
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4.4 Values for an Unknown Case
In a paper on dose estimation created by The Radiation Emergency Assistance
Center/Training Site (REAC/TS), a table is provided with the CDGs for the most
restrictive gamma, beta, and alpha emitter [28]. This is useful in a situation where a
contaminated wound occurs, but the radionuclide is unknown. To be conservative,
if the activity is higher than the most restrictive CDG, decontamination might
need to be considered.
For LWGs, the most restrictive case would be to assume the wound is contam-
inated with a fragment since they are retained at the wound site for the longest
time. Table 4.6 shows a summary of the values to use when the radionuclide is
unknown.
Table 4.6: CDGs and LWGs for unknown cases.
Alpha Beta Gamma
CDG (Bq) 1.3 · 104 8.9 · 106 4.4 · 108
Injection LWG (Bq) 4.31 · 104 2.53 · 107 2.58 · 107
Cut LWG (Bq/cm) 2.05 · 104 4.80 · 107 4.92 · 107
Scrape LWG (Bq/cm2) 4.10 · 104 5.34 · 107 5.45 · 107
Burn LWG (Bq/cm2) 4.10 · 104 5.34 · 107 5.45 · 107
For the alpha emitters, the CDG is based on 241Am, and the LWGs are based
on 244Cm. All limits for beta emitters are from 90Sr, and all limits for the gamma
emitter are for 137Cs. The LWGs for the gamma emitter are more restrictive than
the CDG, however the local dose from 137Cs will be largely due to beta decay,
rather than gamma rays. Photons are of little concern locally because they have a
much farther range than betas and alphas.
4.5 Example Situations
4.5.1 137Cs Wounds
The following example is adapted from a made up example from a REAC/TS
paper, Early Internal and External Dose Magnitude Estimation [28]. Table 4.7
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shows the relevent CDGs and LWGs for this problem.
Table 4.7: Activity limits for 137Cs wound example.
Activity
CDG 1.8 · 107 Bq
Laceration LWG 3.08 · 1010 Bq/cm
Abrasion LWG 1.32 · 109 Bq/cm2
A worker was using a disk grinder to grind welds on contaminated waste con-
tainers. The lid of the waste container unexpectedly broke free due to a weakened
weld, causing the grinder to bounce back into the workers thigh. The worker sat
down to look at his leg, and luckily it was only a shallow wound about 7 cm long.
A second worker who witnessed the incident rushed over to ensure the first worker
was okay. As the second worker knelt down, she sustained a small scrape on her
hand from the floor through a hole in her glove. Due to previous characterisation
of the waste, it was known that the radionuclide of concern was 137Cs.
While the first worker was having his injury looked at to ensure he did not need
medical attention, the second worker had her scrape measured. After the wound
was cleaned, a pancake GM was used to measure the activity, which was 1,200 Bq.
It was assumed there was a 10% detector efficiency, which put the total activity at
12,000 Bq. The size of the abrasion was about 2 cm2, so the activity was well below
the abrasion LWG and it was decided that she did not require further treatment.
Next the first employees wound was measured, and the GM read an activity of
140,000 Bq, for a total activity of 1,400,000 Bq, or 20,000 Bq/cm. This is also well
below the laceration LWG, so this employee also did not need further treatment.
4.5.2 Plutonium Puncture Wounds
Wounds involving plutonium and other alpha emitters have additional challenges
because the tissue surrounding the wound may be able to shield a lot of the ra-
diation [29]. The following examples are real situations that can be modeled as
puncture wounds involving plutonium and its decay products. Table 4.8 shows the
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relevant LWGs and CDGs for these scenarios. The retention category used for all
data is strong, because that is the suggested default category [1].
Table 4.8: Activity limits for plutonium injection examples.
Radionuclide LWG (Bq) CDG (Bq)
Pu238 2.84 · 104 5.5 · 102
Pu239 3.02 · 104 4.9 · 102
Pu240 3.01 · 104 5.2 · 102
Pu241 7.79 · 108 2.7 · 104
Am241 2.84 · 104 4.5 · 102
1985 Hanford Wound
In 1985 a worker at the Hanford Plutonium Recover Facility was using a pointed
stainless steel shaft to try and break up some plutonium sludge in the bottom of a
plastic bottle. The worker was holding the bottle in his left hand, and pushing the
shaft at the sludge with his right. He pushed too hard, and managed to push the
shaft right through the sludge, the bottle, his glove, and into his hand. The shaft
punctured the inside of the workers hand, close to the base of his pointer finger.
The wound was on the side of the finger closer to the middle finger, and while the
shaft did not hit any bones, it went almost all the way through the base of the
finger [30].
Initial measurements of the activity of the wound site were only of 241Am be-
cause the location of the wound did not allow for measuring x-rays from the plu-
tonium. The initial 241Am was measured at 3 kBq [30]. Referring to Table 4.8,
this activity is well above the recommended limits to avoid clinical effects to the
whole body, for 241Am specifically the red blood marrow, and it is also above the
limit for local effects. Since the 241Am in this sludge was ingrown from plutonium,
it would not be unreasonable to assume at the time of the incident that clinically
significant doses could also come from plutonium, in addition to the 241Am.
The medical management of this case involved chelation therapy with DTPA
and surgeries to remove material from the wound site. DTPA was administered
the day of the incident, and continued for about 17 months afterwards. The first
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surgery occured about 7 hours after the incident, and a second surgery was per-
formed on day 9 [31]. After these surgeries measurements showed 418 Bq of 241Am
at the wound site still. This is still above the CDG for 241Am, but it was deter-
mined that further surgery could impact the function of the finger, so they just
monitored the situation [30].
Overall, it was estimated from the excised tissue and bioassay samples that the
original activity at the wound site was 48 kBq. The surgeries reduced the long-term
activity at the wound site to around 5.4 kBq, and 7 kBq was excreted through urine
while taking DTPA. The long term monitoring of the individual did not show any
adverse health effects besides a scar and sensitivity to cold at the wound site [30].
2010 Savannah River Site Wound
In 2010 a worker at Savannah River Site was inspecting transuranic waste canisters
in a glove box. Part of the inspection involved venting the canisters, and then
inserting a flag into the vent hole as a mark that the venting had been completed.
The worker decided to cut the end of the marker and then bent it upwards so it
would not be able to fall out of the canister after it was inserted. However, the
worker punctured his finger on the sharp end of the flag during this process. The
flag punctured through the protective gloves the worker was wearing, and into the
base of his right forefinger [29].
Immediately after the incident, a zinc-sulfide alpha detector was used to mea-
sure the wound and the activity was 300 dpm, or around 18,000 Bq. Consulting
Table 4.8, this is well above the suggested CDGs and LWGs for any isotope of
plutonium, however it was known from previous work that the wound would most
likely be contaminated with 238Pu. Medical personnel managed to reduce the ac-
tivity to 12,000 Bq by cleaning the wound with wipes, as well as soap and water.
Since the activity was still very high, a physician began chelation therapy with
DTPA [29].
After the DTPA was administered, the worker was taken for more wound count-
ing with a high purity germanium detector. In a 10 minute scan, a peak could be
seen at 43.5 keV, which is an extremely low yield (0.04%) gamma for238Pu. The
gloves the worker was wearing at the time of the incident were also measured, and
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the activity at the puncture site was 5.6·109 dpm. Based on these measurements,
it was assumed that the activity at the wound site was significantly higher than
originally measured, a biopsy was performed that removed 14,000 dpm of activity
from the wound site [29]. The high activity removed lead to a surgery to remove
an additional 3,200 Bq the day of the incident, and 3,800 more on day 9. DTPA
was continuted for about 11 months, but stopped when urine bioassays indicated
it was no longer significantly reducing dose to to the worker [29].
4.6 Limitations
The primary limitation in using CDGs or LWGs is that it may not be possible
to get accurate activity readings after a wound occurs due to shielding from the
skin, which was highlighted in the plutonium injection models. In these cases the
measured activity was still higher than the suggested limits, but the full magnitude
of the activity at the wound site could not be measured directly. Care should be
taken to ensure that an activity that appears to be under the suggested limits is
not being underestimated.
Since the dose coefficients were only being calculated for a 1 year time period,
decay products were not included. Of the 38 radionuclides modeled, it is expcected
that 5 will be impacted by this - 99mTc, 106Ru, 226Ra, 228Th, and 232Th. The dose
coefficents for these radionuclides are likely underestimated due to the effects of
decay products.
Finally, it is worth restating that this is not meant as a tool for assigning dose
to incidents, it is a tool to assist in the decision making for decorporation. If a






The purpose of this thesis was to generate local dose coefficients for radionuclide
contamination in wounds. These local dose coefficients can be used to generate
activity levels that could lead to a clinically significant dose for use in emergency
response. Wound models were made for injections, lacerations, abrasions, and
burns. MCNP was used to simulate the dose received per nuclear transformation,
and the biokinetic models for radionuclide retention at the wound sites were used
to calculate the transformation per Bq that would occur at the wound site. A dose
limit of 0.5 Sv in a 1 year time period was used to prevent deterministic effects to
the skin.
The primary source of error in this work comes from adapting the wound models
created for injection wounds to other wound types. However, wounds that can
be modeled as injections are by far the most common in industry, and there are
biokinetic models to describe radionuclide retention for injections.
Overall, it was found that the dose limits for local effects could lead to more
restrictive activity limits than the whole body limits for some radionuclides if they
are strongly retained at the wound site. However the most restrictive case depends
on retention in the body as well as at the wound site, so the use of a CDG or LWG
depends on the radionuclide and initial retention category. Lists of the relevant
activity limits for a facility can be compiled in advance, for use in emergency
response.
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5.2 Future Work
Future work to improve upon quickly assessing if decorporation is required after
a wound would involve looking at the dose received by the body from a gamma
emitter at a wound site. The ORISE paper modeled dose coefficients for radioactive
material introduced through a wound. These dose coefficients are only looking at
material that has been removed from the wound site, it does not consider the impact
of material that remains at the wound site. This work considered the effects of the
material left at the wound site, but only for the area immediately surrounding the
wound. If a gamma emitter is introduced though a wound, and material remains
at the wound site, it will likely not be a concern to the local area due to the range
of gammas in tissue. However, it is possible that a gamma emitter at a wound site
could cause a clinically significant effective or organ dose. A set of activity limits
looking at this possibility for dose would allow for a more thorough idea of the
activity that would be clinically acceptable at the wound site.
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Local Dose Coefficients for
Lacerations
Table B.1: Local dose coefficients for lacerations.
Local Dose Coefficients (Sv/Bq·cm)
Nuclide Weak Moderate Strong Avid Insoluble
H3 4.79E-13 1.01E-12 9.53E-11 2.37E-10 2.95E-10
C14 4.21E-12 8.83E-12 8.56E-10 2.14E-09 2.66E-09
P32 3.69E-11 1.00E-10 8.38E-10 1.12E-09 1.37E-09
S35 3.89E-12 8.50E-12 3.39E-10 6.91E-10 8.57E-10
Fe59 6.77E-12 1.53E-11 3.84E-10 6.88E-10 8.51E-10
Co57 1.68E-12 3.58E-12 2.45E-10 5.70E-10 7.09E-10
Co58 4.23E-12 9.33E-12 3.25E-10 6.38E-10 7.90E-10
Co60 1.65E-11 3.48E-11 3.19E-09 7.90E-09 9.84E-09
Sr85 1.03E-11 2.17E-11 1.80E-09 4.37E-09 5.44E-09
Sr89 4.43E-11 9.95E-11 2.73E-09 5.03E-09 6.22E-09
Sr90 1.66E-11 3.49E-11 3.35E-09 8.36E-09 1.04E-08
Tc99m 6.86E-13 1.42E-12 3.30E-12 3.16E-12 3.42E-12
Ru106 8.42E-13 1.78E-12 1.33E-10 3.16E-10 3.93E-10
I125 1.43E-11 3.17E-11 9.77E-10 1.86E-09 2.30E-09
I129 5.45E-12 1.14E-11 1.11E-09 2.77E-09 3.45E-09
I131 1.05E-11 2.92E-11 2.23E-10 2.89E-10 3.53E-10
Cs134 1.88E-11 3.97E-11 3.37E-09 8.20E-09 1.02E-08
Continued on next page
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Table B.1 – Continued from previous page
Local Dose Coefficients (Sv/Bq·cm)
Nuclide Weak Moderate Strong Avid Insoluble
Cs137 1.62E-11 3.41E-11 3.27E-09 8.17E-09 1.02E-08
Ir192 8.83E-12 1.94E-11 6.96E-10 1.38E-09 1.71E-09
Tl201 4.88E-13 1.56E-12 7.16E-12 7.84E-12 9.43E-12
Po210 3.45E-08 7.43E-08 3.86E-06 8.42E-06 1.05E-05
Ra226 3.24E-08 6.79E-08 6.58E-06 1.64E-05 2.05E-05
Ra228 2.97E-12 6.24E-12 5.76E-10 1.42E-09 1.77E-09
Th228 3.63E-08 7.66E-08 6.43E-06 1.56E-05 1.94E-05
Th230 6.50E-09 1.36E-08 1.32E-06 3.30E-06 4.11E-06
Th232 2.71E-08 5.69E-08 5.52E-06 1.38E-05 1.72E-05
U234 2.84E-08 5.96E-08 5.78E-06 1.44E-05 1.80E-05
U235 2.98E-08 6.25E-08 6.06E-06 1.51E-05 1.89E-05
U238 3.78E-09 7.94E-09 7.70E-07 1.92E-06 2.40E-06
Np237 3.24E-08 6.79E-08 6.58E-06 1.64E-05 2.05E-05
Pu238 3.72E-08 7.81E-08 7.54E-06 1.88E-05 2.35E-05
Pu239 3.49E-08 7.32E-08 7.10E-06 1.77E-05 2.21E-05
Pu240 3.50E-08 7.34E-08 7.11E-06 1.78E-05 2.21E-05
Pu241 1.38E-12 2.89E-12 2.75E-10 6.84E-10 8.52E-10
Am241 3.72E-08 7.80E-08 7.55E-06 1.89E-05 2.35E-05
Cm242 3.99E-08 8.56E-08 4.81E-06 1.07E-05 1.33E-05
Cm244 3.93E-08 8.24E-08 7.87E-06 1.96E-05 2.44E-05
Cf252 3.98E-08 8.39E-08 7.32E-06 1.79E-05 2.23E-05
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Appendix C
Local Dose Coefficients for
Abrasions
Table C.1: Local dose coeffients for abrasions.
Local Dose Coefficients (Sv/Bq·cm2)
Nuclide Weak Moderate Strong Avid Insoluble
H3 4.33E-13 9.10E-13 8.62E-11 2.14E-10 2.67E-10
C14 3.80E-12 7.96E-12 7.72E-10 1.93E-09 2.40E-09
P32 3.37E-11 9.15E-11 7.66E-10 1.02E-09 1.25E-09
S35 3.51E-12 7.66E-12 3.06E-10 6.23E-10 7.73E-10
Fe59 6.67E-12 1.51E-11 3.78E-10 6.78E-10 8.38E-10
Co57 1.58E-12 3.36E-12 2.30E-10 5.35E-10 6.65E-10
Co58 4.56E-12 1.01E-11 3.50E-10 6.88E-10 8.52E-10
Co60 1.63E-11 3.42E-11 3.14E-09 7.78E-09 9.69E-09
Sr85 1.05E-11 2.21E-11 1.84E-09 4.46E-09 5.55E-09
Sr89 4.05E-11 9.09E-11 2.50E-09 4.60E-09 5.68E-09
Sr90 1.50E-11 3.14E-11 3.02E-09 7.52E-09 9.37E-09
Tc99m 6.94E-13 1.44E-12 3.34E-12 3.19E-12 3.46E-12
Ru106 7.62E-13 1.62E-12 1.20E-10 2.86E-10 3.55E-10
I125 1.29E-11 2.87E-11 8.86E-10 1.68E-09 2.08E-09
I129 4.93E-12 1.03E-11 1.00E-09 2.51E-09 3.12E-09
I131 9.62E-12 2.67E-11 2.04E-10 2.65E-10 3.24E-10
Cs134 1.79E-11 3.77E-11 3.20E-09 7.79E-09 9.69E-09
Continued on next page
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Local Dose Coefficients (Sv/Bq·cm2)
Nuclide Weak Moderate Strong Avid Insoluble
Cs137 1.46E-11 3.07E-11 2.95E-09 7.36E-09 9.17E-09
Ir192 8.48E-12 1.87E-11 6.68E-10 1.32E-09 1.64E-09
Tl201 4.42E-13 1.41E-12 6.49E-12 7.10E-12 8.55E-12
Po210 1.72E-08 3.71E-08 1.93E-06 4.21E-06 5.22E-06
Ra226 1.62E-08 3.40E-08 3.29E-06 8.22E-06 1.02E-05
Ra228 1.00E-12 2.10E-12 1.94E-10 4.81E-10 5.99E-10
Th228 1.82E-08 3.83E-08 3.21E-06 7.81E-06 9.72E-06
Th230 3.25E-09 6.82E-09 6.61E-07 1.65E-06 2.06E-06
Th232 1.36E-08 2.84E-08 2.76E-06 6.89E-06 8.58E-06
U234 1.42E-08 2.98E-08 2.89E-06 7.21E-06 8.98E-06
U235 1.49E-08 3.13E-08 3.03E-06 7.57E-06 9.43E-06
U238 1.89E-09 3.97E-09 3.84E-07 9.60E-07 1.20E-06
Np237 1.62E-08 3.39E-08 3.29E-06 8.22E-06 1.02E-05
Pu238 1.86E-08 3.90E-08 3.77E-06 9.42E-06 1.17E-05
Pu239 1.75E-08 3.66E-08 3.55E-06 8.87E-06 1.10E-05
Pu240 1.75E-08 3.67E-08 3.56E-06 8.88E-06 1.11E-05
Pu241 6.62E-13 1.39E-12 1.32E-10 3.29E-10 4.10E-10
Am241 1.86E-08 3.90E-08 3.78E-06 9.43E-06 1.17E-05
Cm242 2.00E-08 4.28E-08 2.41E-06 5.35E-06 6.65E-06
Cm244 1.96E-08 4.12E-08 3.93E-06 9.80E-06 1.22E-05
Cf252 1.99E-08 4.19E-08 3.66E-06 8.96E-06 1.12E-05
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Appendix D
Local Dose Coefficients for Burns
Table D.1: Local dose coefficients for burns.
Local Dose Coefficients (Sv/Bq·cm2)
Nuclide Weak Moderate Strong Avid Insoluble
H3 1.11E-11 4.53E-11 2.28E-10 2.18E-10 2.67E-10
C14 9.90E-11 4.05E-10 2.05E-09 1.96E-09 2.4E-09
P32 2.62E-10 5.34E-10 1.23E-09 1.13E-09 1.25E-09
S35 4.94E-11 1.87E-10 7.03E-10 6.41E-10 7.73E-10
Fe59 7.30E-11 2.5E-10 7.9E-10 7.06E-10 8.38E-10
Co57 3.18E-11 1.28E-10 5.8E-10 5.45E-10 6.65E-10
Co58 5.94E-11 2.19E-10 7.83E-10 7.09E-10 8.52E-10
Co60 4.07E-10 1.66-09 8.28E-09 7.91E-09 9.69E-09
Sr85 2.43E-10 9.88E-10 4.77E-09 4.54E-09 5.55E-09
Sr89 4.64E-10 1.63E-09 5.32E-09 4.77E-09 5.68E-09
Sr90 3.87E-10 1.58E-09 7.98E-09 7.65E-09 9.37E-09
Tc99m 2.75E-12 2.82E-12 3.45E-12 3.44E-12 3.46E-12
Ru106 1.63E-11 6.59E-11 3.08E-10 2.91E-10 3.55E-10
I125 1.57E-10 5.67E-10 1.93E-09 1.74E-09 2.08E-09
I129 1.29E-10 5.26E-10 2.66E-09 2.55E-09 3.12E-09
I131 7.36E-11 1.42E-10 3.2E-10 2.95E-10 3.24E-10
Cs134 4.21E-10 1.71E-09 8.32E-09 7.93E-09 9.69E-09
Cs137 3.79E-10 1.55E-09 7.81E-09 7.49E-09 9.17E-09
Ir192 1.12E-10 4.16E-10 1.5E-09 1.36E-09 1.64E-09
Continued on next page
Appendix D. Local Dose Coefficients for Burns 77
Table D.1 – Continued from previous page
Local Dose Coefficients (Sv/Bq·cm2)
Nuclide Weak Moderate Strong Avid Insoluble
Tl201 3.16E-12 4.36E-12 8.51E-12 8.15E-12 8.55E-12
Po210 2.87E-07 1.12E-06 4.65E-06 4.31E-06 5.22E-06
Ra226 4.22E-07 1.72E-06 8.72E-06 8.36E-06 1.02E-05
Ra228 2.51E-11 1.03E-10 5.11E-10 4.89E-10 5.99E-10
Th228 4.24E-07 1.72E-06 8.35E-06 7.95E-06 9.72E-06
Th230 8.47E-08 3.46E-07 1.75E-06 1.68E-06 2.06E-06
Th232 3.53E-07 1.45E-06 7.31E-06 7.01E-06 8.58E-06
U234 3.70E-07 1.51E-06 7.65E-06 7.34E-06 8.98E-06
U235 3.89E-07 1.59E-06 8.03E-06 7.7E-06 9.43E-06
U238 4.93E-08 2.01E-07 1.02E-06 9.77E-07 1.2E-06
Np237 4.22E-07 1.72E-06 8.72E-06 8.36E-06 1.02E-05
Pu238 4.84E-07 1.98E-06 9.99E-06 9.58E-06 1.17E-05
Pu239 4.55E-07 1.86E-06 9.41E-06 9.02E-06 1.1E-05
Pu240 4.56E-07 1.86E-06 9.42E-06 9.04E-06 1.11E-05
Pu241 1.70E-11 6.95E-11 3.49E-10 3.35E-10 4.1E-10
Am241 4.84E-07 1.98E-06 1E-05 9.6E-06 1.17E-05
Cm242 3.50E-07 1.38E-06 5.88E-06 5.47E-06 6.65E-06
Cm244 5.06E-07 2.07E-06 1.04E-05 9.96E-06 1.22E-05
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































There are four sample codes provided. They show the code used for each wound
model - injection, abrasion/burn, laceration, and healed laceration. One of each
of the particle files is also shown - betas, monoenergetic electrons, photons, and
alphas. All example files are for 238U.
















Appendix H. Sample MCNP Codes 95
m1 6000 -0.204 $ Skin
1001 -0.1 7014 -0.042
8016 -0.645 11023 -0.002 15031 -0.001





sdef erg=d1 pos=0 0 0 par=e
SI1 H 0 0.0032 0.01 0.03 0.085 0.2 0.4 0.7 1.1 4













1 1 -1.09 -4 2 3 -1 -5 6 (-8 :-7 :4 :5 :-6 )
2 2 -0.001225 8 7 -4 -5 6











7 p 0 0 0 0 0 1 0.02183 0.5 0






m1 6000 -0.204 $ Skin
1001 -0.1 7014 -0.042
8016 -0.645 11023 -0.002 15031 -0.001
16000 -0.002 17000 -0.003 19000 -0.001
m2 7014 -0.755636 $ Air
8016 -0.231475 18036 -3.9e-005 18038 -8e-006
18040 -0.012842
c *****************************************************************
imp:e 1 1 0
imp:p 1 1 0
c *****************************************************************
sdef erg=d1 cel=1 x=0 y=-0.0001 z=d2 par=e
SI1 L 0 0.0000513 0.000133126 0.000188109 0.000497239 0.00177878
0.0023265 0.0027442 0.00994648 0.0130815 0.0162528 0.029072
0.02977 0.033235 0.0455138 0.04955 0.09372 0.097185 0.109464
SP1 D 0 0.255890281985544 0.283142843539434 0.162422781915094
4.15791139445232E-02 6.59551038756999E-03 9.21969234679901E-02
1.58965551361563E-02 2.45437730968023E-02 0.012238803238341
1.44148567249367E-03 0.00259239 0.0804199 0.0710334 0.0422661
0.0145956 0.000275944 0.000184771 0.000131314
Appendix H. Sample MCNP Codes 97
si2 H -0.4999 0.4999






Healed Laceration and Photon File




1 1 -1.09 -4 2 3 -1 -5 6















m1 6000 -0.204 $ Skin
1001 -0.1 7014 -0.042
Appendix H. Sample MCNP Codes 98
8016 -0.645 11023 -0.002 15031 -0.001





sdef erg=d1 cel=1 x=0 y=-0.0001 z=d2 par=p
SI1 L 0 0.0000823 0.000103399 0.000105427 0.000114329 0.000124762
0.000227924 0.000425129 0.00056677 0.000847487 0.00094569
0.00125834 0.0017108 0.0028505 0.00517584 0.00674846 0.0119354
0.0250558 0.0303626 0.04955 0.1135







si2 H -0.4999 0.4999











1 1 -1.09 3 -4 5 -1 -6 7
Appendix H. Sample MCNP Codes 99
2 2 -0.001225 -4 2 -3 5 -6 7
















m1 6000 -0.204 $ Skin
1001 -0.1 7014 -0.042
8016 -0.645 11023 -0.002 15031 -0.001
16000 -0.002 17000 -0.003 19000 -0.001
m2 7014 -0.755636 $ Air
8016 -0.231475 18036 -3.9e-005 18038 -8e-006
18040 -0.012842
c *****************************************************************
imp:a 1 1 0
c *****************************************************************
sdef erg=d1 sur=3 vec=1 0 0 x=0 y=d2 z=d3 par=a
cut:A j 0.1
SI1 L 0 0.00545 0.00642087 0.282129 0.681002
SP1 D 0 5.5897328689226E-03 6.58549506166588E-03
Appendix H. Sample MCNP Codes 100
0.289362521940599 0.698462250128813
si2 H -0.4999 0.4999
sp2 D 0 1
si3 H -0.4999 0.4999
sp3 D 0 1
+F6 1
c *****************************************************************
Print 110
NPS 500000
